Point-of-Care Technology Market Report 2026

Point-of-Care Technology Market Overview

• Point-of-Care Technology market size has reached to $43.21 billion in 2025 • Expected to grow to $67.94 billion in 2030 at a compound annual growth rate (CAGR) of 9.4% • Growth Driver: Growing Prevalence Of Chronic Illnesses Fueling The Growth Of The Market Due To Rising Sedentary Lifestyles And Increasing Risk Of Heart Disease And Diabetes • Market Trend: AI-Powered Diagnostic Platform Enables Rapid On-Site Cancer Testing • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Point-of-Care Technology Market?

Point-of-care technology refers to medical diagnostic devices and tools used at or near the site of patient care, such as clinics, hospitals, or even homes. It is used to provide rapid, accurate, and real-time diagnostic results, enabling timely clinical decisions and improving patient outcomes. Point-of-care technology minimizes the need for centralized laboratory testing and accelerates treatment initiation. The main product types of point-of-care technology are diagnostic devices, monitoring devices, therapeutic devices, and data management systems. Diagnostic devices are tools designed to detect and identify diseases or health conditions by analyzing biological samples such as blood, saliva, or urine. These solutions are offered under various ownership models, including standalone solutions, integrated solutions, and cloud-based solutions, and utilize technologies such as microfluidics, polymerase chain reaction (PCR), and immunoassays. They serve a wide range of applications, including infectious disease testing, glucose monitoring, cardiometabolic monitoring, pregnancy and fertility testing, and others, and cater to diverse end users such as hospitals, clinics, homecare settings, and ambulatory surgical centers.

What Is The Point-of-Care Technology Market Growth Forecast?

The point-of-care technology market size is expected to see strong growth in the next few years. It will grow to $67.94 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to advancement in microfluidics and pcr technologies, rising prevalence of chronic and lifestyle diseases, growth in homecare and decentralized healthcare models, increasing healthcare digitization, supportive regulatory frameworks for rapid diagnostics. Major trends in the forecast period include rising demand for rapid diagnostic testing at point of care, increasing adoption of home-based and remote testing solutions, growth in portable and handheld diagnostic devices, expansion of infectious disease and chronic disease testing, improved focus on ease of use and faster turnaround time.

Global Point-of-Care Technology Market Segmentation

1) By Product Type: Diagnostics Devices, Monitoring Devices, Therapeutic Devices, Data Management Systems 2) By Ownership Model: Standalone Solutions, Integrated Solutions, Cloud-Based Solutions 3) By Technology: Microfluidics, Polymerase Chain Reaction (PCR), Immunoassays 4) By Application: Infectious Disease Testing, Glucose Monitoring, Cardiometabolic Monitoring, Pregnancy And Fertility Testing, Other Applications 5) By End-User: Hospitals, Clinics, Homecare Settings, Ambulatory Surgical Centers Subsegments: 1) By Diagnostics Devices: Blood Glucose Monitoring Devices, Infectious Disease Testing Devices, Cardiac Marker Testing Devices, Coagulation Testing Devices, Pregnancy And Fertility Testing Devices, Urinalysis Testing Devices, Hematology Testing Devices, Cholesterol Testing Devices 2) By Monitoring Devices: Vital Signs Monitoring Devices, Continuous Glucose Monitoring Devices, Cardiac Monitoring Devices, Respiratory Monitoring Devices 3) By Therapeutic Devices: Insulin Delivery Devices, Nebulizers, Dialysis Machines, Infusion Pumps 4) By Data Management Systems: Point Of Care (POC) Data Integration Systems, Point Of Care (POC) Middleware Solutions, Point Of Care (POC) Data Analytics Platforms

What Is The Driver Of The Point-of-Care Technology Market?

The growing prevalence of chronic illnesses is expected to propel the growth of the point-of-care technology market going forward. Chronic illnesses are persistent health conditions that last for an extended period and typically need continuous care and lifestyle adjustments. Chronic illnesses are increasing due to inactive lifestyles, as prolonged sitting and minimal physical activity raise the risk of diseases such as heart conditions and diabetes. Point-of-care technology helps manage chronic illnesses by offering rapid, on-site diagnostic testing, making it ideal for clinics, homes, and remote care settings. It reduces delays in treatment by providing real-time results, improving patient monitoring, and overall healthcare convenience. For instance, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, marking an 18% increase from 3,065,825 cases in 2022. Therefore, the growing prevalence of chronic illnesses is driving the growth of the point-of-care technology industry.

Key Players In The Global Point-of-Care Technology Market

Major companies operating in the point-of-care technology market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Hologic Inc., bioMérieux SA, Quidel Corporation, Sysmex Corporation, Cepheid Inc., Radiometer Medical ApS, Nova Biomedical, Sekisui Diagnostics LLC, Abaxis Inc., BHR Biosynex, EKF Diagnostics Holdings plc, Acon Laboratories Inc., Trinity Biotech plc, Chembio Diagnostics Inc., Arkray Inc., Orchard Software Corporation, Point of Care Biomedical Private Limited

Global Point-of-Care Technology Market Trends and Insights

Major companies operating in the point-of-care technology market are focusing on developing technologically advanced solutions, AI-powered diagnostic platforms, to improve accuracy, speed, and accessibility in disease detection. AI-powered diagnostic platforms refer to cutting-edge systems that leverage artificial intelligence to analyze medical data rapidly, enabling real-time, on-site testing for critical conditions such as cancer. For instance, in February 2025, Avitia Inc., a Canada-based point-of-care diagnostics company, launched an AI-powered platform designed for rapid and point-of-care cancer testing. The platform integrates machine learning algorithms with portable diagnostic devices, allowing healthcare providers to deliver fast, precise cancer screening outside traditional lab settings. This innovation reduces turnaround times, enhances early detection, and minimizes the need for complex infrastructure, making advanced diagnostics more accessible in remote or underserved areas.

What Are Latest Mergers And Acquisitions In The Point-of-Care Technology Market?

In July 2024, F. Hoffmann-La Roche AG, a Switzerland-based pharmaceutical company, acquired the point-of-care technology platform from LumiraDx Group Limited for approximately $350 million. With this acquisition, Roche aims to strengthen its position in the decentralized diagnostics space by integrating a user-friendly, portable platform capable of immunochemistry and clinical chemistry testing, with future potential for molecular diagnostics. Lumiradx Group Limited is a UK-based diagnostics company that provides next-generation point-of-care diagnostic technologies.

Regional Outlook

North America was the largest region in the point-of-care technology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Point-of-Care Technology Market?

The point-of-care technology market consists of revenues earned by entities by providing services such as rapid diagnostic testing, decentralized patient monitoring, emergency response diagnostics, and personalized treatment support. The market value includes the value of related goods sold by the service provider or included within the service offering. The point-of-care technology market also includes sales of handheld diagnostic devices, portable analyzers, lab-on-a-chip systems, digital test kits, and connected biosensors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.